Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate
Public ClinicalTrials.gov record NCT03659929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Fixed-Dose, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of AR19 (Amphetamine Sulfate) in Adult Subjects (Ages 18-55) With Attention Deficit Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the AR19.004 study is to assess the efficacy of AR19 compared to placebo using the Adult ADHD Investigator Symptom Rating Scale (AISRS)
Study identification
- NCT ID
- NCT03659929
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 320 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 18, 2018 (Actual)
- Primary completion
- Apr 12, 2019 (Actual)
- Completion
- Apr 12, 2019 (Actual)
- Last update posted
- Sep 3, 2024
2018 – 2019
United States locations
- U.S. sites
- 31
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 114: Pharmacology Research Institute | Encino | California | 91316 | — |
| 133: Collaborative Neuroscience Network | Garden Grove | California | 92845 | — |
| 124: Pharmacology Research Institute | Newport Beach | California | 92660 | — |
| 121: CT Clinical Research Associates | Cromwell | Connecticut | 06416 | — |
| 108: Meridien Research | Bradenton | Florida | 34201 | — |
| 103: Gulfcoast Clinical Research Center | Fort Myers | Florida | 33912 | — |
| 129: Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| 105: Meridien Research | Lakeland | Florida | 33805 | — |
| 120: Meridien Research | Maitland | Florida | 32751 | — |
| 130: Medical Research Group of Central Florida | Orange City | Florida | 32763 | — |
| 123: APG Research, LLC | Orlando | Florida | 32803 | — |
| 115: Clinical Neuroscience Solutions (CNS), Inc. | Orlando | Florida | 32806 | — |
| 104: Northwest Behavioral Research Center | Marietta | Georgia | 30060 | — |
| 131: Advanced Clinical Research, Inc. | Meridian | Idaho | 86342 | — |
| 113: Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| 134: Rochester Center for Behavioral Medicine | Rochester Hills | Michigan | 48307 | — |
| 128: Clinical Neurophysiology Services | Sterling | Michigan | 48314 | — |
| 107: Center for Psychiatry and Behavioral Medicine | Las Vegas | Nevada | 89128 | — |
| 116: Alliance - Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| 127: Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| 101: Princeton Medical Institute | Princeton | New Jersey | 08540 | — |
| 118: Bioscience Research, LLC | Mount Kisco | New York | 10549 | — |
| 119: Neurobehavioral Clinical Research, Inc. | Canton | Ohio | 44718 | — |
| 106: Summit Research Network | Portland | Oregon | 97210 | — |
| 126: Coastal Carolina Research | Mt. Pleasant | South Carolina | 29464 | — |
| 102: Clinical Neuroscience Solutions (CNS), Inc. | Memphis | Tennessee | 38119 | — |
| 132: Research Strategies of Memphis | Memphis | Tennessee | 38119 | — |
| 125: Biobehavioral Research of Austin | Austin | Texas | 78759 | — |
| 110: FutureSearch Trials of Dallas | Dallas | Texas | 75231 | — |
| 117: Houston Clinical Trials, LLC | Houston | Texas | 77005 | — |
| 109: Ericksen Research and Development | Clinton | Utah | 84405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03659929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03659929 live on ClinicalTrials.gov.